Acute pyelonephritis
"acute pyelonephritis"[MeSH Terms]

| Factor | Mechanism |
|---|---|
| Urinary outflow obstruction (BPH, calculi, uterine prolapse) | Urinary stasis allows bacterial growth |
| Vesicoureteral reflux (VUR) | Present in 20-40% of children with UTI; incompetent ureterovesical valve allows infected urine to reflux into renal pelvis |
| Diabetes mellitus | Increased infection susceptibility + neurogenic bladder → stasis |
| Pregnancy | Uterine pressure causes stasis; progesterone causes ureteral smooth muscle relaxation and dilatation |
| Immunosuppression | Reduced host defense |
| Pre-existing renal scarring | Intraparenchymal obstruction |
| Organism | Notes |
|---|---|
| E. coli | By far the most common (75%+ of uncomplicated cases) |
| Klebsiella pneumoniae | Second most common |
| Proteus mirabilis | Urease producer; associated with struvite stones |
| Enterobacter spp. | |
| Pseudomonas aeruginosa | More common in complicated/nosocomial cases |
| Staphylococcus aureus | Hematogenous route; in people who inject drugs, endocarditis |
| Enterococcus faecalis | Particularly in complicated/catheter-associated UTI |


Only ~7% of adult females with acute pyelonephritis require hospitalization in population-based studies. - Comprehensive Clinical Nephrology 7e
| Drug | Dose / Duration | Notes |
|---|---|---|
| Ciprofloxacin (first-line if susceptibility confirmed) | 500 mg BID x 5-7 days | Fluoroquinolones achieve excellent tissue levels |
| Levofloxacin | 750 mg OD x 5-7 days | |
| Trimethoprim-sulfamethoxazole | DS BID x 14 days | Use only if local E. coli resistance <20% |
| Cefixime (oral) | 400 mg OD x 7-14 days | After initial parenteral dose |
| Drug | Notes |
|---|---|
| Aminoglycosides (gentamicin) | Initial IV; associated with better outcomes; preferred in areas with high resistance |
| Ceftriaxone (IV) | Broad-spectrum; step down to oral cephalosporin |
| Piperacillin-tazobactam | 4.5 g q8h x 7 days for complicated/resistant cases |
| Meropenem | 1 g q8h x 4-5 days for ESBL/resistant organisms |
| Plazomicin | 15 mg/kg once daily for complicated/resistant cases |
/generatehandwrittenimage downsyndrome
Handwritten medical student notes on lined paper about Down Syndrome (Trisomy 21). The notes are written in blue and black ink in a neat handwriting style with headings underlined. Include the following sections clearly written out: DOWN SYNDROME (TRISOMY 21) Incidence: 1 in 700 live births — most common chromosomal disorder GENETICS: • Trisomy 21 (95%) — meiotic nondisjunction, karyotype 47,XX,+21 • Translocation (4%) — long arm of chr 21 to chr 14 or 22 (often familial, Robertsonian) • Mosaic (1%) — mitotic nondisjunction; milder phenotype • Maternal age effect: risk ↑ with age (1:1550 at <20 yrs → 1:25 at >45 yrs) • Extra chromosome is of maternal origin in 95% of cases CLINICAL FEATURES: • Flat facial profile, oblique palpebral fissures, epicanthic folds • Simian (single palmar) crease • Hypotonia, short neck, protruding tongue, low-set ears • Intellectual disability (IQ 25–50 in 80%), delayed milestones • Short stature COMPLICATIONS: ❤ Congenital heart disease (40%) — endocardial cushion defects, ASD, VSD 🔬 Leukemia — 10–20× increased risk (ALL + AML) 🧠 Alzheimer disease — ALL patients >40 yrs develop Alzheimer changes; 30% develop dementia by age 60 🦠 Abnormal immune responses — recurrent lung infections, thyroid autoimmunity ⚡ Epilepsy, hypothyroidism (↑ risk) 🦴 Atlantoaxial instability (10–20%) GI: Hirschsprung disease, duodenal atresia Eyes: cataracts, refractive errors DIAGNOSIS: • Prenatal: maternal serum β-hCG ↑, PAPP-A ↓, nuchal fold thickening • Cell-free fetal DNA (liquid biopsy) — sensitive & specific • Confirmed by amniocentesis / karyotype TREATMENT: • No specific therapy • Manage complications: cardiac surgery, leukemia treatment, thyroid screening, spine precautions • Supportive education and environment
400, message: Got more than 4194304 bytes when reading: b'data: {"candidates": [{"content": {"role": "model","parts": [{"inlineData": {"mimeType": "image/png"...'.
We encountered an error while processing your request. Please try again or reach out to us for help.
/generatehandwrittenimage /generatehandwrittenimage downsyndrome
Handwritten medical student notes on lined white paper, written in blue and black ballpoint pen, neat cursive and print mix handwriting style, with headings underlined in red pen. The notes read: DOWN SYNDROME (TRISOMY 21) Incidence: 1 in 700 live births — most common chromosomal disorder GENETICS: - Trisomy 21 (95%) — meiotic nondisjunction → karyotype 47,XX,+21 - Translocation (4%) — chr 21 long arm fused to chr 14 or 22; familial (Robertsonian) - Mosaic (1%) — mitotic nondisjunction; milder phenotype - Maternal age effect: risk rises sharply with age (1:1550 at age <20 yrs vs 1:25 at age >45 yrs) - Extra chr 21 is maternal in origin in 95% of cases CLINICAL FEATURES: - Flat facial profile, oblique palpebral fissures, epicanthic folds - Single palmar (simian) crease - Hypotonia, short neck, protruding tongue - Intellectual disability (IQ 25–50 in ~80%) - Short stature, delayed milestones ASSOCIATIONS / COMPLICATIONS: - Congenital heart disease (40%) — ASD, VSD, endocardial cushion defects - Leukemia risk x10–20 (ALL and AML) - Alzheimer disease — ALL pts >40 yrs develop plaques/tangles - Hypothyroidism, epilepsy (increased risk) - Atlantoaxial instability (10–20%) - GI: duodenal atresia, Hirschsprung disease - Eyes: cataracts, refractive errors - Recurrent infections (T-cell dysfunction) PRENATAL DIAGNOSIS: - Serum: beta-hCG ↑, PAPP-A ↓ - Ultrasound: nuchal fold thickening - Cell-free fetal DNA (liquid biopsy) — highly sensitive - Confirmed by amniocentesis + karyotype MANAGEMENT: - No disease-specific therapy - Treat complications: cardiac surgery, leukemia Rx, thyroid screen - Cervical spine precautions before anaesthesia - Supportive education + multidisciplinary care
400, message: Got more than 4194304 bytes when reading: b'data: {"candidates": [{"content": {"role": "model","parts": [{"inlineData": {"mimeType": "image/png"...'.
We encountered an error while processing your request. Please try again or reach out to us for help.